'The Department of Health has commissioned quite a lot of work, and NICE will play a significant role, but beyond that we don’t know very much more than [the public],'
Merck & Co. are the latest drug company to resort to court action to try and save the intellectual property of two of their patents in India, signalling a tougher stance from an industry under increasing pressure from generic competition.
Pharmaceutical direct-to-consumer advertising (DTC) dropped by 11.5% last year which was a $2 billion drop from its peak in 2006.
India’s Supreme Court rejected Novartis’ patent application for the cancer drug Glivec yesterday. A victory for the Indian drug industry, but the result may have repercussions on India’s attempts to attract foreign investment
Global pharma firms, dismayed by recent intellectual property decisions in India, are awaiting a landmark court ruling next week that could have severe implications on their ability to sell branded medicines in the country.
Budget cuts slashing American spending on healthcare and research by US$85bn (£56bn) as part of a ten-year schedule aimed to save US$1.2 trillion, will begin next week, making public health sector take a hit surpassed only by trimmings made in defense.
Johnson and Johnson recalls their OneTouch Verio line of blood glucose meters, after the death of a patient.
Pharmaceutical innovation – and breakthrough success – is assessed by looking at the percentage of a company’s sales that comes from products approved in the last 5 years. Yet, regardless of potential, new drugs grow slowly, and many firms are depending on ‘old reliables’ for sales revenue.
Setting up the right sites, in addition to recruitment and patient retention, makes trials of treatments for rare diseases challenging, a survey of clinical development decision-makers, conducted by Premier Research, has revealed.
Today, US federal regulators will argue at the Supreme Court that it should be illegal for companies holding pharmaceutical patents to make payments to delay rival generic drug manufacturers from marketing cheaper drug versions.
"A successful segmentation plan lets you get the return you expect. You have to do your...
US spending on specialty drugs – drugs aimed at chronic, complex diseases such as cancer, multiple...
Revision of China’s Good Supply Practice for Pharmaceutical Products took almost three years to...